{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05559164",
            "orgStudyIdInfo": {
                "id": "042201"
            },
            "secondaryIdInfos": [
                {
                    "id": "Pro2022000290",
                    "type": "OTHER",
                    "domain": "Rutgers, The State University of New Jersey"
                }
            ],
            "organization": {
                "fullName": "Rutgers, The State University of New Jersey",
                "class": "OTHER"
            },
            "briefTitle": "Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted",
            "officialTitle": "STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy",
            "therapeuticArea": [
                "Cardiovascular",
                "Oncology and Hematology"
            ],
            "study": "statins-for-reduction-of-cardiac-toxicity-in-patients-receiving-targeted"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-09-26",
            "studyFirstSubmitQcDate": "2022-09-26",
            "studyFirstPostDateStruct": {
                "date": "2022-09-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mridula George, MD",
                "investigatorTitle": "Assistant Professor of Medicine",
                "investigatorAffiliation": "Rutgers, The State University of New Jersey"
            },
            "leadSponsor": {
                "name": "Rutgers, The State University of New Jersey",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with anti-HER2 therapy.",
            "detailedDescription": "A single arm open-label phase 2 study to evaluate the cardioprotective effects of statins in patients with Stage I-III HER2 positive breast cancer receiving HER2 targeted therapy. This study will evaluate the hypothesis that addition of statins will reduce treatment delays/discontinuations related to symptomatic/asymptomatic cardiac dysfunction in patients being treated with anti-HER2 therapy. The long-term goal of this study is to improve disease related outcomes and quality of life measures in patients being treated with anti-HER2 therapy."
        },
        "conditionsModule": {
            "conditions": [
                "Cardiac Toxicity",
                "Early-stage Breast Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Stage I-III HER2positive breast cancer receiving anti-HER2 therapy. Participants will receive Lipitor 40 mg PO daily.\n\nAnti-HER2 targeted therapy + Lipitor 40mg daily",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Anti-HER2 targeted therapy + Lipitor 40mg daily",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive Lipitor 40 mg PO daily while receiving anti-HER2 therapy.",
                    "interventionNames": [
                        "Drug: Lipitor 40mg Tablet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Lipitor 40mg Tablet",
                    "description": "LIPITOR\u00ae (atorvastatin calcium) tablets will be administered orally as a single dose of 40 mg once daily, with or without food",
                    "armGroupLabels": [
                        "Anti-HER2 targeted therapy + Lipitor 40mg daily"
                    ],
                    "otherNames": [
                        "Atorvastatin Calcium"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants With at Least One Adverse Event will be measured using Common Terminology Criteria for Adverse Events (CTCAE) v5.0 for five years",
                    "description": "Adverse events (AEs) will be measured using Common Terminology Criteria for Adverse Events (CTCAE) v5.0 for five years",
                    "timeFrame": "Five years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Patient reported outcome (PRO) for pain measured by the quality of Life questionnaire using PROMIS to measure pain",
                    "description": "Quality of Life questionnaire using PROMIS will be administered at baseline, six, twelve and fifteen months",
                    "timeFrame": "Baseline, six, twelve and fifteen months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Patient reported outcome (PRO) for pain measured by the quality of Life questionnaire using PROMIS to measure fatigue",
                    "description": "Quality of Life questionnaire using PROMIS will be administered at baseline six, twelve and fifteen months",
                    "timeFrame": "Baseline, six, twelve and fifteen months"
                },
                {
                    "measure": "Patient reported outcome (PRO) for pain measured by the quality of Life questionnaire using PROMIS to measure physical functioning",
                    "description": "Quality of Life questionnaire using PROMIS will be administered at baseline six, twelve and fifteen months to measure physical functioning",
                    "timeFrame": "Baseline, six, twelve and fifteen months"
                },
                {
                    "measure": "Patient reported outcome (PRO) for pain measured by the quality of Life questionnaire using PROMIS to measure emotional distress",
                    "description": "Quality of Life questionnaire using PROMIS will be administered at baseline six, twelve and fifteen months to measure emotional distress",
                    "timeFrame": "Baseline, six, twelve and fifteen months"
                },
                {
                    "measure": "Patient reported outcome (PRO) for pain measured by the quality of Life questionnaire using PROMIS to measure social participation",
                    "description": "Quality of Life questionnaire using PROMIS will be administered at baseline six, twelve and fifteen months to measure social participation",
                    "timeFrame": "Baseline, six, twelve and fifteen months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically and/or cytologically confirmed diagnosis of Stage I-III female breast cancer (including inflammatory breast cancer)\n* Scheduled to receive neoadjuvant/adjuvant HER2 targeted therapy\n* Between \u226518 years of age\n* Female patients of childbearing potential must have a negative pregnancy test (serum or urine) prior to enrollment. Female patients must agree to use effective barrier contraception during the period of therapy\n* Baseline LVEF \u2265 50%\n* Prior cancers allowed if no evidence of disease in last 5 years\n* ECOG 0-2\n* No prior history of treatment with HER2 targeted therapy or anthracyclines based chemotherapy\n* Adequate bone marrow function:\n\nI. ANC \u2265 1000/uL II. platelet count \u2265 100,000/uL III. hemoglobin \u2265 9.0 g/dL\n\n\u2022 Adequate hepatic function: I. Total bilirubin \u2264 1.5 X ULN II. AST (SGOT) \u2264 5 X ULN III. ALT (SGPT) \u2264 5 X ULN\n\n* Adequate renal function, Creatinine \\< 1.5x institutional ULN or calculated creatinine clearance \u2265 50 mL/min as estimated using the Cockcroft-Gault formula\n* Ability to understand the nature of this study protocol and give written informed consent\n* Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures\n\nExclusion Criteria:\n\n* Participants with stage IV breast cancer\n* Participants currently taking statins\n* Uncontrolled hypertension (systolic blood pressure \\>190 mm Hg or diastolic blood pressure \\>100 mm Hg)\n* No active liver disease\n* Current use of CYP 3A4 inhibitors\n* Any condition including the presence of laboratory abnormalities, which, in the opinion of the investigator places the subject at unacceptable risk if he/she were to participate in the study\n* Life expectancy \\< 12 weeks\n* Pregnancy (positive pregnancy test) or lactation\n* Pre-existing sensory neuropathy \\> grade one\n* Has significant cardiovascular disease, such as:\n\nLVEF \\< 50% at baseline as assessed by ECHO (preferred) i) Class III or Class IV myocardial disease as described by the New York Heart Association ii) Recent history (within 6 months prior to enrollment) of myocardial infarction; or iii) Symptomatic arrhythmia at the time of randomization\n\n* Major surgery without complete recovery in the past four weeks prior to screening\n* Concurrent active infection\n* Participant with uncontrolled and/ or active infection with HIV, Hepatitis B or Hepatitis C\n* Participant who has a history of allergy or hypersensitivity to any of the study drugs\n* Participant with a history of interstitial lung disease, history of slowly progressive dyspnea and unproductive cough, sarcoidosis, silicosis, interstitial pulmonary fibrosis, pulmonary hypersensitivity pneumonitis\n* Any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "\u2022 Female patients of childbearing potential must have a negative pregnancy test (serum or urine) prior to enrollment. Female patients must agree to use effective barrier contraception during the period of therapy.",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mridula George, MD",
                    "role": "CONTACT",
                    "phone": "732-235-9081",
                    "email": "mridula@cinj.rutgers.edu"
                },
                {
                    "name": "Coral Omene, MD",
                    "role": "CONTACT",
                    "phone": "732-235-3374",
                    "email": "co273@cinj.rutgers.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mridula George, MD",
                    "affiliation": "Rutgers Cancer Institute of New Jersey",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Trinitas Hospital and Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Elizabeth",
                    "state": "New Jersey",
                    "zip": "07202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-9081",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.66399,
                        "lon": -74.2107
                    }
                },
                {
                    "facility": "RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "state": "New Jersey",
                    "zip": "08690",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-2465",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.20706,
                        "lon": -74.08125
                    }
                },
                {
                    "facility": "RWJBarnabas Health - - Jersey City Medical Medical",
                    "status": "RECRUITING",
                    "city": "Jersey City",
                    "state": "New Jersey",
                    "zip": "07097",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-9081",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.72816,
                        "lon": -74.07764
                    }
                },
                {
                    "facility": "Monmouth Medical Center Southern Campus",
                    "status": "RECRUITING",
                    "city": "Lakewood",
                    "state": "New Jersey",
                    "zip": "08701",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-9081",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.09789,
                        "lon": -74.21764
                    }
                },
                {
                    "facility": "RWJBarnabas Health - Monmouth Medical Center",
                    "status": "RECRUITING",
                    "city": "Long Branch",
                    "state": "New Jersey",
                    "zip": "07740",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-9081",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.30428,
                        "lon": -73.99236
                    }
                },
                {
                    "facility": "Monmouth Community Medical",
                    "status": "RECRUITING",
                    "city": "Long Branch",
                    "state": "New Jersey",
                    "zip": "07764",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-222-6046",
                            "email": "mridula@CINJ.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.30428,
                        "lon": -73.99236
                    }
                },
                {
                    "facility": "Rutgers Cancer Institute of New Jersey",
                    "status": "RECRUITING",
                    "city": "New Brunswick",
                    "state": "New Jersey",
                    "zip": "08903",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-9081",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.48622,
                        "lon": -74.45182
                    }
                },
                {
                    "facility": "RWJBarnabas Health - Robert Wood Johnson University Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New Brunswick",
                    "state": "New Jersey",
                    "zip": "08903",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-9081",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.48622,
                        "lon": -74.45182
                    }
                },
                {
                    "facility": "RWJBarnabas Health - Newark Beth Israel Medical Center",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "New Jersey",
                    "zip": "07112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-2465",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.73566,
                        "lon": -74.17237
                    }
                },
                {
                    "facility": "RWJBarnabas Health - Robert Wood Johnson University Hospital",
                    "status": "RECRUITING",
                    "city": "Somerset",
                    "state": "New Jersey",
                    "zip": "08873",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mridula George, MD",
                            "role": "CONTACT",
                            "phone": "732-235-2465",
                            "email": "mridula@cinj.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4976,
                        "lon": -74.48849
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000066126",
                    "term": "Cardiotoxicity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000064420",
                    "term": "Drug-Related Side Effects and Adverse Reactions"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000011832",
                    "term": "Radiation Injuries"
                },
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M30670",
                    "name": "Cardiotoxicity",
                    "asFound": "Cardiac Toxicity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M30303",
                    "name": "Drug-Related Side Effects and Adverse Reactions",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14679",
                    "name": "Radiation Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069059",
                    "term": "Atorvastatin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000924",
                    "term": "Anticholesteremic Agents"
                },
                {
                    "id": "D000000960",
                    "term": "Hypolipidemic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000057847",
                    "term": "Lipid Regulating Agents"
                },
                {
                    "id": "D000019161",
                    "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M351",
                    "name": "Atorvastatin",
                    "asFound": "Out",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M21155",
                    "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4243",
                    "name": "Anticholesteremic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4278",
                    "name": "Hypolipidemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M28883",
                    "name": "Lipid Regulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Lipd",
                    "name": "Lipid Regulating Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}